Logo-bi
Review

1. Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2014;4(2): 55-67. doi: 10.5681/bi.2014.021
PMCID: PMC4097973     PMID: 25035848     Scopus ID: 84905435584    
Article
PDF
XML
Cited By:
117
40
0
Review

2. Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumors
Marziyeh Fathi, Jaleh Barar* ORCID
Bioimpacts. 2017;7(1): 49-57. doi: 10.15171/bi.2017.07
PMCID: PMC5439389     PMID: 28546953     Scopus ID: 85019106716    
Article
PDF
Full Text
XML
Cited By:
32
10
25
Editorial

3. Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Mohammad Hossein Somi* ORCID
Bioimpacts. 2019;9(3): 123-127. doi: 10.15171/bi.2019.16
PMCID: PMC6726747     PMID: 31508327     Scopus ID: 85071152476    
Article
PDF
Full Text
XML
Cited By:
20
9
19
Colorectal cancer (CRC) as a malignancy shows high mortality rate worldwide because of metastasis and drug resistance. Targeted multimodal nanosystems (NSs) can be developed and used against CRC with much better clinical outcomes.
Perspective

4. Optogenetics: A new tool for cancer investigation and treatment
Siamak Alizadeh ORCID, Abolghasem Esmaeili, Jaleh Barar ORCID, Yadollah Omidi* ORCID
BioImpacts. 2022;12(4): 295-299. doi: 10.34172/bi.2021.22179
PMCID: PMC9376163     PMID: 35975208     Scopus ID: 85137389032    
Article
PDF
Full Text
XML
Cited By:
1
0
0
Optogenetics approaches can provide us with outstanding tool to extend our understanding of how cells perceive, respond, and behave in meeting with complex signals, particularly in terms of cancer evasion from the anticancer immune system functions.
Original Research

5. TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer
Efthymia-Iliana Matthaiou ORCID, Yi Guo, Jaleh Barar ORCID, Raphael Sandaltzopoulos, Lana E. Kandalaft, Chunsheng Li*, George Coukos, Yadollah Omidi* ORCID
Bioimpacts. 2022;12(1): 65-86. doi: 10.34172/bi.2021.23511
PMCID: PMC8783079     PMID: 35087718     Scopus ID: 85127176631    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
2
1
0
Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) functionalized with polyethylene glycol (PEG)and anti-TEM1 antibody fragment (78Fc) and loaded with necrosis-inducing agent shikonin (SHK)(78Fc-PLGA-SHK NPs) is a highly effective immunostimulating nanomedicine against theTEM1-expressing cells for targeted therapy of solid tumors.

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge